The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cell Multiplex Assay Technology Market Research Report 2024
Synopsis
Market Analysis and Insights: Global Cell Multiplex Assay Technology Market
The global Cell Multiplex Assay Technology market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Consumables accounting for % of the Cell Multiplex Assay Technology global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Pharmaceutical & Biotechnology Companies segment is altered to an % CAGR throughout this forecast period.
China Cell Multiplex Assay Technology market size is valued at US$ million in 2021, while the North America and Europe Cell Multiplex Assay Technology are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cell Multiplex Assay Technology landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell Multiplex Assay Technology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell Multiplex Assay Technology market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell Multiplex Assay Technology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell Multiplex Assay Technology market.
Global Cell Multiplex Assay Technology Scope and Market Size
Cell Multiplex Assay Technology market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cell Multiplex Assay Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Consumables
Instruments
Software & Services
Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Luminex Corporation (US)
Thermo Fisher Scientific Inc. (US)
Illumina, Inc (US)
Bio-Rad Laboratories, Inc. (US)
Qiagen N.V. (Netherlands)
Abcam plc (UK)
Becton, Dickinson and Company (US)
Merck KGaA (Germany)
Agilent Technologies, Inc. (US)
Meso Scale Diagnostics (US)
Randox Laboratories (UK)
Quanterix (US)
Bio-Techne Corporation (US)
Olink (Sweden)
DiaSorin S.p.A. (Italy)
Seegene (South Korea)
Promega Corporation (US)
Siemens Healthineers (Germany)
PerkinElmer, Inc. (US)
Shimadzu Biotech (Japan)
Antigenix America, Inc. (US)
Enzo Life Sciences, Inc. (US)
Boster Biological Technology (US)
AYOXXA Biosystems GmbH (Germany)
Cayman Chemical Company (US)
Market Analysis and Insights: Global Cell Multiplex Assay Technology Market
The global Cell Multiplex Assay Technology market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Consumables accounting for % of the Cell Multiplex Assay Technology global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Pharmaceutical & Biotechnology Companies segment is altered to an % CAGR throughout this forecast period.
China Cell Multiplex Assay Technology market size is valued at US$ million in 2021, while the North America and Europe Cell Multiplex Assay Technology are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cell Multiplex Assay Technology landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cell Multiplex Assay Technology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cell Multiplex Assay Technology market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cell Multiplex Assay Technology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cell Multiplex Assay Technology market.
Global Cell Multiplex Assay Technology Scope and Market Size
Cell Multiplex Assay Technology market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cell Multiplex Assay Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Consumables
Instruments
Software & Services
Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Luminex Corporation (US)
Thermo Fisher Scientific Inc. (US)
Illumina, Inc (US)
Bio-Rad Laboratories, Inc. (US)
Qiagen N.V. (Netherlands)
Abcam plc (UK)
Becton, Dickinson and Company (US)
Merck KGaA (Germany)
Agilent Technologies, Inc. (US)
Meso Scale Diagnostics (US)
Randox Laboratories (UK)
Quanterix (US)
Bio-Techne Corporation (US)
Olink (Sweden)
DiaSorin S.p.A. (Italy)
Seegene (South Korea)
Promega Corporation (US)
Siemens Healthineers (Germany)
PerkinElmer, Inc. (US)
Shimadzu Biotech (Japan)
Antigenix America, Inc. (US)
Enzo Life Sciences, Inc. (US)
Boster Biological Technology (US)
AYOXXA Biosystems GmbH (Germany)
Cayman Chemical Company (US)
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell Multiplex Assay Technology Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Consumables
1.2.3 Instruments
1.2.4 Software & Services
1.3 Market by Application
1.3.1 Global Cell Multiplex Assay Technology Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals & Research Institutes
1.3.4 Reference Laboratories
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cell Multiplex Assay Technology Market Perspective (2017-2028)
2.2 Cell Multiplex Assay Technology Growth Trends by Region
2.2.1 Cell Multiplex Assay Technology Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cell Multiplex Assay Technology Historic Market Size by Region (2017-2022)
2.2.3 Cell Multiplex Assay Technology Forecasted Market Size by Region (2023-2028)
2.3 Cell Multiplex Assay Technology Market Dynamics
2.3.1 Cell Multiplex Assay Technology Industry Trends
2.3.2 Cell Multiplex Assay Technology Market Drivers
2.3.3 Cell Multiplex Assay Technology Market Challenges
2.3.4 Cell Multiplex Assay Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell Multiplex Assay Technology Players by Revenue
3.1.1 Global Top Cell Multiplex Assay Technology Players by Revenue (2017-2022)
3.1.2 Global Cell Multiplex Assay Technology Revenue Market Share by Players (2017-2022)
3.2 Global Cell Multiplex Assay Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell Multiplex Assay Technology Revenue
3.4 Global Cell Multiplex Assay Technology Market Concentration Ratio
3.4.1 Global Cell Multiplex Assay Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell Multiplex Assay Technology Revenue in 2021
3.5 Cell Multiplex Assay Technology Key Players Head office and Area Served
3.6 Key Players Cell Multiplex Assay Technology Product Solution and Service
3.7 Date of Enter into Cell Multiplex Assay Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell Multiplex Assay Technology Breakdown Data by Type
4.1 Global Cell Multiplex Assay Technology Historic Market Size by Type (2017-2022)
4.2 Global Cell Multiplex Assay Technology Forecasted Market Size by Type (2023-2028)
5 Cell Multiplex Assay Technology Breakdown Data by Application
5.1 Global Cell Multiplex Assay Technology Historic Market Size by Application (2017-2022)
5.2 Global Cell Multiplex Assay Technology Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cell Multiplex Assay Technology Market Size (2017-2028)
6.2 North America Cell Multiplex Assay Technology Market Size by Country (2017-2022)
6.3 North America Cell Multiplex Assay Technology Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cell Multiplex Assay Technology Market Size (2017-2028)
7.2 Europe Cell Multiplex Assay Technology Market Size by Country (2017-2022)
7.3 Europe Cell Multiplex Assay Technology Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell Multiplex Assay Technology Market Size (2017-2028)
8.2 Asia-Pacific Cell Multiplex Assay Technology Market Size by Country (2017-2022)
8.3 Asia-Pacific Cell Multiplex Assay Technology Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cell Multiplex Assay Technology Market Size (2017-2028)
9.2 Latin America Cell Multiplex Assay Technology Market Size by Country (2017-2022)
9.3 Latin America Cell Multiplex Assay Technology Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell Multiplex Assay Technology Market Size (2017-2028)
10.2 Middle East & Africa Cell Multiplex Assay Technology Market Size by Country (2017-2022)
10.3 Middle East & Africa Cell Multiplex Assay Technology Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Luminex Corporation (US)
11.1.1 Luminex Corporation (US) Company Detail
11.1.2 Luminex Corporation (US) Business Overview
11.1.3 Luminex Corporation (US) Cell Multiplex Assay Technology Introduction
11.1.4 Luminex Corporation (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.1.5 Luminex Corporation (US) Recent Development
11.2 Thermo Fisher Scientific Inc. (US)
11.2.1 Thermo Fisher Scientific Inc. (US) Company Detail
11.2.2 Thermo Fisher Scientific Inc. (US) Business Overview
11.2.3 Thermo Fisher Scientific Inc. (US) Cell Multiplex Assay Technology Introduction
11.2.4 Thermo Fisher Scientific Inc. (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.2.5 Thermo Fisher Scientific Inc. (US) Recent Development
11.3 Illumina, Inc (US)
11.3.1 Illumina, Inc (US) Company Detail
11.3.2 Illumina, Inc (US) Business Overview
11.3.3 Illumina, Inc (US) Cell Multiplex Assay Technology Introduction
11.3.4 Illumina, Inc (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.3.5 Illumina, Inc (US) Recent Development
11.4 Bio-Rad Laboratories, Inc. (US)
11.4.1 Bio-Rad Laboratories, Inc. (US) Company Detail
11.4.2 Bio-Rad Laboratories, Inc. (US) Business Overview
11.4.3 Bio-Rad Laboratories, Inc. (US) Cell Multiplex Assay Technology Introduction
11.4.4 Bio-Rad Laboratories, Inc. (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.4.5 Bio-Rad Laboratories, Inc. (US) Recent Development
11.5 Qiagen N.V. (Netherlands)
11.5.1 Qiagen N.V. (Netherlands) Company Detail
11.5.2 Qiagen N.V. (Netherlands) Business Overview
11.5.3 Qiagen N.V. (Netherlands) Cell Multiplex Assay Technology Introduction
11.5.4 Qiagen N.V. (Netherlands) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.5.5 Qiagen N.V. (Netherlands) Recent Development
11.6 Abcam plc (UK)
11.6.1 Abcam plc (UK) Company Detail
11.6.2 Abcam plc (UK) Business Overview
11.6.3 Abcam plc (UK) Cell Multiplex Assay Technology Introduction
11.6.4 Abcam plc (UK) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.6.5 Abcam plc (UK) Recent Development
11.7 Becton, Dickinson and Company (US)
11.7.1 Becton, Dickinson and Company (US) Company Detail
11.7.2 Becton, Dickinson and Company (US) Business Overview
11.7.3 Becton, Dickinson and Company (US) Cell Multiplex Assay Technology Introduction
11.7.4 Becton, Dickinson and Company (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.7.5 Becton, Dickinson and Company (US) Recent Development
11.8 Merck KGaA (Germany)
11.8.1 Merck KGaA (Germany) Company Detail
11.8.2 Merck KGaA (Germany) Business Overview
11.8.3 Merck KGaA (Germany) Cell Multiplex Assay Technology Introduction
11.8.4 Merck KGaA (Germany) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.8.5 Merck KGaA (Germany) Recent Development
11.9 Agilent Technologies, Inc. (US)
11.9.1 Agilent Technologies, Inc. (US) Company Detail
11.9.2 Agilent Technologies, Inc. (US) Business Overview
11.9.3 Agilent Technologies, Inc. (US) Cell Multiplex Assay Technology Introduction
11.9.4 Agilent Technologies, Inc. (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.9.5 Agilent Technologies, Inc. (US) Recent Development
11.10 Meso Scale Diagnostics (US)
11.10.1 Meso Scale Diagnostics (US) Company Detail
11.10.2 Meso Scale Diagnostics (US) Business Overview
11.10.3 Meso Scale Diagnostics (US) Cell Multiplex Assay Technology Introduction
11.10.4 Meso Scale Diagnostics (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.10.5 Meso Scale Diagnostics (US) Recent Development
11.11 Randox Laboratories (UK)
11.11.1 Randox Laboratories (UK) Company Detail
11.11.2 Randox Laboratories (UK) Business Overview
11.11.3 Randox Laboratories (UK) Cell Multiplex Assay Technology Introduction
11.11.4 Randox Laboratories (UK) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.11.5 Randox Laboratories (UK) Recent Development
11.12 Quanterix (US)
11.12.1 Quanterix (US) Company Detail
11.12.2 Quanterix (US) Business Overview
11.12.3 Quanterix (US) Cell Multiplex Assay Technology Introduction
11.12.4 Quanterix (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.12.5 Quanterix (US) Recent Development
11.13 Bio-Techne Corporation (US)
11.13.1 Bio-Techne Corporation (US) Company Detail
11.13.2 Bio-Techne Corporation (US) Business Overview
11.13.3 Bio-Techne Corporation (US) Cell Multiplex Assay Technology Introduction
11.13.4 Bio-Techne Corporation (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.13.5 Bio-Techne Corporation (US) Recent Development
11.14 Olink (Sweden)
11.14.1 Olink (Sweden) Company Detail
11.14.2 Olink (Sweden) Business Overview
11.14.3 Olink (Sweden) Cell Multiplex Assay Technology Introduction
11.14.4 Olink (Sweden) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.14.5 Olink (Sweden) Recent Development
11.15 DiaSorin S.p.A. (Italy)
11.15.1 DiaSorin S.p.A. (Italy) Company Detail
11.15.2 DiaSorin S.p.A. (Italy) Business Overview
11.15.3 DiaSorin S.p.A. (Italy) Cell Multiplex Assay Technology Introduction
11.15.4 DiaSorin S.p.A. (Italy) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.15.5 DiaSorin S.p.A. (Italy) Recent Development
11.16 Seegene (South Korea)
11.16.1 Seegene (South Korea) Company Detail
11.16.2 Seegene (South Korea) Business Overview
11.16.3 Seegene (South Korea) Cell Multiplex Assay Technology Introduction
11.16.4 Seegene (South Korea) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.16.5 Seegene (South Korea) Recent Development
11.17 Promega Corporation (US)
11.17.1 Promega Corporation (US) Company Detail
11.17.2 Promega Corporation (US) Business Overview
11.17.3 Promega Corporation (US) Cell Multiplex Assay Technology Introduction
11.17.4 Promega Corporation (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.17.5 Promega Corporation (US) Recent Development
11.18 Siemens Healthineers (Germany)
11.18.1 Siemens Healthineers (Germany) Company Detail
11.18.2 Siemens Healthineers (Germany) Business Overview
11.18.3 Siemens Healthineers (Germany) Cell Multiplex Assay Technology Introduction
11.18.4 Siemens Healthineers (Germany) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.18.5 Siemens Healthineers (Germany) Recent Development
11.19 PerkinElmer, Inc. (US)
11.19.1 PerkinElmer, Inc. (US) Company Detail
11.19.2 PerkinElmer, Inc. (US) Business Overview
11.19.3 PerkinElmer, Inc. (US) Cell Multiplex Assay Technology Introduction
11.19.4 PerkinElmer, Inc. (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.19.5 PerkinElmer, Inc. (US) Recent Development
11.20 Shimadzu Biotech (Japan)
11.20.1 Shimadzu Biotech (Japan) Company Detail
11.20.2 Shimadzu Biotech (Japan) Business Overview
11.20.3 Shimadzu Biotech (Japan) Cell Multiplex Assay Technology Introduction
11.20.4 Shimadzu Biotech (Japan) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.20.5 Shimadzu Biotech (Japan) Recent Development
11.21 Antigenix America, Inc. (US)
11.21.1 Antigenix America, Inc. (US) Company Detail
11.21.2 Antigenix America, Inc. (US) Business Overview
11.21.3 Antigenix America, Inc. (US) Cell Multiplex Assay Technology Introduction
11.21.4 Antigenix America, Inc. (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.21.5 Antigenix America, Inc. (US) Recent Development
11.22 Enzo Life Sciences, Inc. (US)
11.22.1 Enzo Life Sciences, Inc. (US) Company Detail
11.22.2 Enzo Life Sciences, Inc. (US) Business Overview
11.22.3 Enzo Life Sciences, Inc. (US) Cell Multiplex Assay Technology Introduction
11.22.4 Enzo Life Sciences, Inc. (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.22.5 Enzo Life Sciences, Inc. (US) Recent Development
11.23 Boster Biological Technology (US)
11.23.1 Boster Biological Technology (US) Company Detail
11.23.2 Boster Biological Technology (US) Business Overview
11.23.3 Boster Biological Technology (US) Cell Multiplex Assay Technology Introduction
11.23.4 Boster Biological Technology (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.23.5 Boster Biological Technology (US) Recent Development
11.24 AYOXXA Biosystems GmbH (Germany)
11.24.1 AYOXXA Biosystems GmbH (Germany) Company Detail
11.24.2 AYOXXA Biosystems GmbH (Germany) Business Overview
11.24.3 AYOXXA Biosystems GmbH (Germany) Cell Multiplex Assay Technology Introduction
11.24.4 AYOXXA Biosystems GmbH (Germany) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.24.5 AYOXXA Biosystems GmbH (Germany) Recent Development
11.25 Cayman Chemical Company (US)
11.25.1 Cayman Chemical Company (US) Company Detail
11.25.2 Cayman Chemical Company (US) Business Overview
11.25.3 Cayman Chemical Company (US) Cell Multiplex Assay Technology Introduction
11.25.4 Cayman Chemical Company (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022)
11.25.5 Cayman Chemical Company (US) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Cell Multiplex Assay Technology Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Consumables
Table 3. Key Players of Instruments
Table 4. Key Players of Software & Services
Table 5. Global Cell Multiplex Assay Technology Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Cell Multiplex Assay Technology Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Cell Multiplex Assay Technology Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Cell Multiplex Assay Technology Market Share by Region (2017-2022)
Table 9. Global Cell Multiplex Assay Technology Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Cell Multiplex Assay Technology Market Share by Region (2023-2028)
Table 11. Cell Multiplex Assay Technology Market Trends
Table 12. Cell Multiplex Assay Technology Market Drivers
Table 13. Cell Multiplex Assay Technology Market Challenges
Table 14. Cell Multiplex Assay Technology Market Restraints
Table 15. Global Cell Multiplex Assay Technology Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Cell Multiplex Assay Technology Market Share by Players (2017-2022)
Table 17. Global Top Cell Multiplex Assay Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Multiplex Assay Technology as of 2021)
Table 18. Ranking of Global Top Cell Multiplex Assay Technology Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Cell Multiplex Assay Technology Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cell Multiplex Assay Technology Product Solution and Service
Table 22. Date of Enter into Cell Multiplex Assay Technology Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cell Multiplex Assay Technology Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Cell Multiplex Assay Technology Revenue Market Share by Type (2017-2022)
Table 26. Global Cell Multiplex Assay Technology Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Cell Multiplex Assay Technology Revenue Market Share by Type (2023-2028)
Table 28. Global Cell Multiplex Assay Technology Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Cell Multiplex Assay Technology Revenue Market Share by Application (2017-2022)
Table 30. Global Cell Multiplex Assay Technology Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Cell Multiplex Assay Technology Revenue Market Share by Application (2023-2028)
Table 32. North America Cell Multiplex Assay Technology Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Cell Multiplex Assay Technology Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Cell Multiplex Assay Technology Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Cell Multiplex Assay Technology Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Cell Multiplex Assay Technology Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Cell Multiplex Assay Technology Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Cell Multiplex Assay Technology Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Cell Multiplex Assay Technology Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Cell Multiplex Assay Technology Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Cell Multiplex Assay Technology Market Size by Country (2023-2028) & (US$ Million)
Table 42. Luminex Corporation (US) Company Detail
Table 43. Luminex Corporation (US) Business Overview
Table 44. Luminex Corporation (US) Cell Multiplex Assay Technology Product
Table 45. Luminex Corporation (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 46. Luminex Corporation (US) Recent Development
Table 47. Thermo Fisher Scientific Inc. (US) Company Detail
Table 48. Thermo Fisher Scientific Inc. (US) Business Overview
Table 49. Thermo Fisher Scientific Inc. (US) Cell Multiplex Assay Technology Product
Table 50. Thermo Fisher Scientific Inc. (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 51. Thermo Fisher Scientific Inc. (US) Recent Development
Table 52. Illumina, Inc (US) Company Detail
Table 53. Illumina, Inc (US) Business Overview
Table 54. Illumina, Inc (US) Cell Multiplex Assay Technology Product
Table 55. Illumina, Inc (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 56. Illumina, Inc (US) Recent Development
Table 57. Bio-Rad Laboratories, Inc. (US) Company Detail
Table 58. Bio-Rad Laboratories, Inc. (US) Business Overview
Table 59. Bio-Rad Laboratories, Inc. (US) Cell Multiplex Assay Technology Product
Table 60. Bio-Rad Laboratories, Inc. (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 61. Bio-Rad Laboratories, Inc. (US) Recent Development
Table 62. Qiagen N.V. (Netherlands) Company Detail
Table 63. Qiagen N.V. (Netherlands) Business Overview
Table 64. Qiagen N.V. (Netherlands) Cell Multiplex Assay Technology Product
Table 65. Qiagen N.V. (Netherlands) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 66. Qiagen N.V. (Netherlands) Recent Development
Table 67. Abcam plc (UK) Company Detail
Table 68. Abcam plc (UK) Business Overview
Table 69. Abcam plc (UK) Cell Multiplex Assay Technology Product
Table 70. Abcam plc (UK) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 71. Abcam plc (UK) Recent Development
Table 72. Becton, Dickinson and Company (US) Company Detail
Table 73. Becton, Dickinson and Company (US) Business Overview
Table 74. Becton, Dickinson and Company (US) Cell Multiplex Assay Technology Product
Table 75. Becton, Dickinson and Company (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 76. Becton, Dickinson and Company (US) Recent Development
Table 77. Merck KGaA (Germany) Company Detail
Table 78. Merck KGaA (Germany) Business Overview
Table 79. Merck KGaA (Germany) Cell Multiplex Assay Technology Product
Table 80. Merck KGaA (Germany) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 81. Merck KGaA (Germany) Recent Development
Table 82. Agilent Technologies, Inc. (US) Company Detail
Table 83. Agilent Technologies, Inc. (US) Business Overview
Table 84. Agilent Technologies, Inc. (US) Cell Multiplex Assay Technology Product
Table 85. Agilent Technologies, Inc. (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 86. Agilent Technologies, Inc. (US) Recent Development
Table 87. Meso Scale Diagnostics (US) Company Detail
Table 88. Meso Scale Diagnostics (US) Business Overview
Table 89. Meso Scale Diagnostics (US) Cell Multiplex Assay Technology Product
Table 90. Meso Scale Diagnostics (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 91. Meso Scale Diagnostics (US) Recent Development
Table 92. Randox Laboratories (UK) Company Detail
Table 93. Randox Laboratories (UK) Business Overview
Table 94. Randox Laboratories (UK) Cell Multiplex Assay TechnologyProduct
Table 95. Randox Laboratories (UK) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 96. Randox Laboratories (UK) Recent Development
Table 97. Quanterix (US) Company Detail
Table 98. Quanterix (US) Business Overview
Table 99. Quanterix (US) Cell Multiplex Assay TechnologyProduct
Table 100. Quanterix (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 101. Quanterix (US) Recent Development
Table 102. Bio-Techne Corporation (US) Company Detail
Table 103. Bio-Techne Corporation (US) Business Overview
Table 104. Bio-Techne Corporation (US) Cell Multiplex Assay TechnologyProduct
Table 105. Bio-Techne Corporation (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 106. Bio-Techne Corporation (US) Recent Development
Table 107. Olink (Sweden) Company Detail
Table 108. Olink (Sweden) Business Overview
Table 109. Olink (Sweden) Cell Multiplex Assay TechnologyProduct
Table 110. Olink (Sweden) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 111. Olink (Sweden) Recent Development
Table 112. DiaSorin S.p.A. (Italy) Company Detail
Table 113. DiaSorin S.p.A. (Italy) Business Overview
Table 114. DiaSorin S.p.A. (Italy) Cell Multiplex Assay TechnologyProduct
Table 115. DiaSorin S.p.A. (Italy) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 116. DiaSorin S.p.A. (Italy) Recent Development
Table 117. Seegene (South Korea) Company Detail
Table 118. Seegene (South Korea) Business Overview
Table 119. Seegene (South Korea) Cell Multiplex Assay TechnologyProduct
Table 120. Seegene (South Korea) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 121. Seegene (South Korea) Recent Development
Table 122. Promega Corporation (US) Company Detail
Table 123. Promega Corporation (US) Business Overview
Table 124. Promega Corporation (US) Cell Multiplex Assay TechnologyProduct
Table 125. Promega Corporation (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 126. Promega Corporation (US) Recent Development
Table 127. Siemens Healthineers (Germany) Company Detail
Table 128. Siemens Healthineers (Germany) Business Overview
Table 129. Siemens Healthineers (Germany) Cell Multiplex Assay TechnologyProduct
Table 130. Siemens Healthineers (Germany) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 131. Siemens Healthineers (Germany) Recent Development
Table 132. PerkinElmer, Inc. (US) Company Detail
Table 133. PerkinElmer, Inc. (US) Business Overview
Table 134. PerkinElmer, Inc. (US) Cell Multiplex Assay TechnologyProduct
Table 135. PerkinElmer, Inc. (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 136. PerkinElmer, Inc. (US) Recent Development
Table 137. Shimadzu Biotech (Japan) Company Detail
Table 138. Shimadzu Biotech (Japan) Business Overview
Table 139. Shimadzu Biotech (Japan) Cell Multiplex Assay TechnologyProduct
Table 140. Shimadzu Biotech (Japan) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 141. Shimadzu Biotech (Japan) Recent Development
Table 142. Antigenix America, Inc. (US) Company Detail
Table 143. Antigenix America, Inc. (US) Business Overview
Table 144. Antigenix America, Inc. (US) Cell Multiplex Assay TechnologyProduct
Table 145. Antigenix America, Inc. (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 146. Antigenix America, Inc. (US) Recent Development
Table 147. Enzo Life Sciences, Inc. (US) Company Detail
Table 148. Enzo Life Sciences, Inc. (US) Business Overview
Table 149. Enzo Life Sciences, Inc. (US) Cell Multiplex Assay TechnologyProduct
Table 150. Enzo Life Sciences, Inc. (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 151. Enzo Life Sciences, Inc. (US) Recent Development
Table 152. Boster Biological Technology (US) Company Detail
Table 153. Boster Biological Technology (US) Business Overview
Table 154. Boster Biological Technology (US) Cell Multiplex Assay TechnologyProduct
Table 155. Boster Biological Technology (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 156. Boster Biological Technology (US) Recent Development
Table 157. AYOXXA Biosystems GmbH (Germany) Company Detail
Table 158. AYOXXA Biosystems GmbH (Germany) Business Overview
Table 159. AYOXXA Biosystems GmbH (Germany) Cell Multiplex Assay TechnologyProduct
Table 160. AYOXXA Biosystems GmbH (Germany) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 161. AYOXXA Biosystems GmbH (Germany) Recent Development
Table 162. Cayman Chemical Company (US) Company Detail
Table 163. Cayman Chemical Company (US) Business Overview
Table 164. Cayman Chemical Company (US) Cell Multiplex Assay TechnologyProduct
Table 165. Cayman Chemical Company (US) Revenue in Cell Multiplex Assay Technology Business (2017-2022) & (US$ Million)
Table 166. Cayman Chemical Company (US) Recent Development
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Multiplex Assay Technology Market Share by Type: 2021 VS 2028
Figure 2. Consumables Features
Figure 3. Instruments Features
Figure 4. Software & Services Features
Figure 5. Global Cell Multiplex Assay Technology Market Share by Application in 2021 & 2028
Figure 6. Pharmaceutical & Biotechnology Companies Case Studies
Figure 7. Hospitals & Research Institutes Case Studies
Figure 8. Reference Laboratories Case Studies
Figure 9. Other Case Studies
Figure 10. Cell Multiplex Assay Technology Report Years Considered
Figure 11. Global Cell Multiplex Assay Technology Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Cell Multiplex Assay Technology Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Cell Multiplex Assay Technology Market Share by Region: 2021 VS 2028
Figure 14. Global Cell Multiplex Assay Technology Market Share by Players in 2021
Figure 15. Global Top Cell Multiplex Assay Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Multiplex Assay Technology as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Cell Multiplex Assay Technology Revenue in 2021
Figure 17. North America Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Cell Multiplex Assay Technology Market Share by Country (2017-2028)
Figure 19. United States Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Cell Multiplex Assay Technology Market Share by Country (2017-2028)
Figure 23. Germany Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Cell Multiplex Assay Technology Market Share by Region (2017-2028)
Figure 31. China Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Cell Multiplex Assay Technology Market Share by Country (2017-2028)
Figure 39. Mexico Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Cell Multiplex Assay Technology Market Share by Country (2017-2028)
Figure 43. Turkey Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Cell Multiplex Assay Technology Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Luminex Corporation (US) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 46. Thermo Fisher Scientific Inc. (US) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 47. Illumina, Inc (US) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 48. Bio-Rad Laboratories, Inc. (US) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 49. Qiagen N.V. (Netherlands) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 50. Abcam plc (UK) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 51. Becton, Dickinson and Company (US) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 52. Merck KGaA (Germany) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 53. Agilent Technologies, Inc. (US) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 54. Meso Scale Diagnostics (US) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 55. Randox Laboratories (UK) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 56. Quanterix (US) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 57. Bio-Techne Corporation (US) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 58. Olink (Sweden) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 59. DiaSorin S.p.A. (Italy) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 60. Seegene (South Korea) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 61. Promega Corporation (US) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 62. Siemens Healthineers (Germany) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 63. PerkinElmer, Inc. (US) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 64. Shimadzu Biotech (Japan) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 65. Antigenix America, Inc. (US) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 66. Enzo Life Sciences, Inc. (US) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 67. Boster Biological Technology (US) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 68. AYOXXA Biosystems GmbH (Germany) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 69. Cayman Chemical Company (US) Revenue Growth Rate in Cell Multiplex Assay Technology Business (2017-2022)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
